Therapy News and Research

RSS

Alarming cardiovascular disease statistics highlighted in 2025 report

Heart disease kills more people than any other cause as many of the risks factors that contribute to it remain on the rise, according the data reported in the 2025 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association.

27 Jan 2025

Updated guidelines for preventing and managing hepatitis B virus reactivation

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

27 Jan 2025

LVRS may outperform EBV in patients with severe emphysema

As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for advanced emphysema may survive longer and with fewer complications than they did in the past-and they may even fare better than those who opt for endobronchial valve (EBV) placement.

27 Jan 2025

Triple therapy shows strong response in BRAF V600E mutant metastatic colorectal cancer

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy regimen, according to results from the Phase III BREAKWATER trial led by researchers at The University of Texas MD Anderson Cancer Center.

26 Jan 2025

Blood test for ctDNA identifies patients who benefit from celecoxib after surgery

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit from adding of celecoxib, to post surgery treatment.

26 Jan 2025

New dye offers breakthrough in deep tissue imaging and cancer therapy

Researchers from Tokyo Metropolitan University have developed a new dye that can strongly absorb second near-IR radiation and transform it to heat.

25 Jan 2025

Study shows how the sound affects balance in people with vestibular hypofunction

The vestibular system is a network of organs in the inner ears that detects the motions and position of the head.

25 Jan 2025

New procedure standard/practice guideline released for fibroblast activation protein PET

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have issued a new procedure standard/practice guideline for the use of fibroblast activation protein (FAP) PET.

25 Jan 2025

University Hospitals introduces endoscopic spine surgery for back pain patients with herniated discs

University Hospitals is now offering endoscopic spine surgery for patients needing treatment for back pain due to herniated discs in their spine.

24 Jan 2025

Immune environment found to influence success of leukemia immunotherapy

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field of cancer immunotherapy.

24 Jan 2025

Researchers identify key factors for successful donor lymphocyte infusion in AML patients

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have relapsed after allogenic hematopoietic stem cell transplant, will successfully move the patient into remission.

24 Jan 2025

New light-based technique could transform heart tissue repair

Researchers from Mass General Brigham and collaborating institutions have developed a non-invasive approach to manipulate cardiac tissue activity by using light to stimulate an innovative ink incorporated into bioprinted tissue.

24 Jan 2025

Breakthrough gene discovery offers new hope for medulloblastoma therapy

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.

24 Jan 2025

NUS researchers develop DNA barcoded nanoparticles for targeted cancer therapy

A team of researchers from the National University of Singapore (NUS) has developed a novel method to enhance the precision of cancer treatment using gold nanoparticles tagged with DNA barcodes.

24 Jan 2025

Key immune cells required for tissue repair following liver injury

Our livers contain many different types of immune cells. New research by the team of Prof. Charlotte Scott (VIB-UGent Center for Inflammation Research) and colleagues now reveals that a specific activation state of one of these cell types is required for tissue repair following injury.

24 Jan 2025

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing the likelihood of diabetes remission.

24 Jan 2025

Study offers new insight into how nature and nurture shape aggression in males

Like humans, mice will compete over territory and mates, and show increased confidence in their fighting skills the more they win.

24 Jan 2025

Uncertainty surrounds effects of puberty blockers and hormone therapy for gender dysphoria

Major uncertainties remain about the impact of puberty blockers and gender affirming hormone therapy on children and young people with gender related distress (gender dysphoria), making it impossible to determine conclusively whether they help or harm, find two pooled data analyses of the available evidence, published online in the Archives of Disease in Childhood.

23 Jan 2025

Study finds link between impairments in physical function and hospital readmission risk

Researchers from The Ohio State University Wexner Medical Center and College of Medicine's School of Health and Rehabilitation Sciences (HRS) recently published a study that found a link between impairments in physical function and hospital readmission risk among adults 50 years of age and older.

23 Jan 2025

New approach to treating ependymoma with leukemia drug

Rakesh Jain PhD, Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk Cook Professor of Radiation Oncology at Harvard Medical School, is senior author of a new study in PNAS, Targeting EPHB2/ABL1 Restores Anti-Tumor Immunity in Preclinical Models of Ependymoma.

23 Jan 2025

Therapy News and Research

Alarming cardiovascular disease statistics highlighted in 2025 report

Updated guidelines for preventing and managing hepatitis B virus reactivation

LVRS may outperform EBV in patients with severe emphysema

Triple therapy shows strong response in BRAF V600E mutant metastatic colorectal cancer

Blood test for ctDNA identifies patients who benefit from celecoxib after surgery

New dye offers breakthrough in deep tissue imaging and cancer therapy

Study shows how the sound affects balance in people with vestibular hypofunction

New procedure standard/practice guideline released for fibroblast activation protein PET

University Hospitals introduces endoscopic spine surgery for back pain patients with herniated discs

Immune environment found to influence success of leukemia immunotherapy

Researchers identify key factors for successful donor lymphocyte infusion in AML patients

New light-based technique could transform heart tissue repair

Breakthrough gene discovery offers new hope for medulloblastoma therapy

NUS researchers develop DNA barcoded nanoparticles for targeted cancer therapy

Key immune cells required for tissue repair following liver injury

Dapagliflozin plus calorie restriction boosts remission rates in adults with type 2 diabetes and obesity

Study offers new insight into how nature and nurture shape aggression in males

Uncertainty surrounds effects of puberty blockers and hormone therapy for gender dysphoria

Study finds link between impairments in physical function and hospital readmission risk

New approach to treating ependymoma with leukemia drug

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News